Table 1.
Demographic data of human subjects
| Items | RA patients | HC subjects |
|---|---|---|
| Gender (M/F) | 10/10 | 10/10 |
| Age (mean ± s.d.; years) | 44·5 ± 6·5 | 41·4 ± 5·3 |
| RA history (years) | 6·6 ± 3·1 | n.a. |
| ESR (mm/h) | 38·3 ± 4·4* | 8·8 ± 2·1 |
| Rheumatoid factor positive | 20 (100%) | 0 |
| Serum IL‐4 (pg/ml) | 28·3 ± 4·2* | 5·5 ± 2·5 |
| Serum IL‐13 (pg/ml) | 55·2 ± 6·8* | 11·4 ± 3·2 |
| Serum IL‐17 (pg/ml) | 46·5 ± 6·7* | 12·5 ± 3·2 |
| Serum TNF (pg/ml) | 76·7 ± 8·6* | 12·2 ± 3·4 |
| Serum IFN‐γ (pg/ml) | 55·8 ± 7·6* | 8·8 ± 2·3 |
Data are presented as mean ± standard deviation (s.d.). RA = rheumatoid arthritis; ESR = erythrocyte sedimentation rate; HC = healthy control; IL = interleukin; TNF = tumor necrosis factor; IFN = interferon; M/F = male/female; n.a. = not available.
*
P < 0·01 (t‐test), compared with HC group.